Ken Griffin Cyclacel Pharmaceuticals, Inc. Transaction History

Citadel Advisors LLC

  • $509 Billion
  • Q1 2025

A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Cyclacel Pharmaceuticals, Inc. stock. As of the latest transaction made, Citadel Advisors LLC holds 12,171 shares of CYCCP stock, worth $0. This represents 0.0% of its overall portfolio holdings.

Number of Shares
12,171
Holding current value
$0
% of portfolio
0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 15, 2025
BUY
N/A
12,171 New
12,171 $0
Q1 2023

May 15, 2023
BUY
N/A
48,230 New
48,230 $0

Others Institutions Holding CYCCP

# of Institutions
5
Shares Held
20.4K
Call Options Held
0
Put Options Held
0
View Full List

About Cyclacel Pharmaceuticals, Inc.

CYCCP Quotes by TradingView
  • Ticker CYCCP
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 12,497,400
  • Market Cap $16.5M
More about CYCCP
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email